Artigos com autorizações de acesso público - Aedin CulhaneSaiba mais
GeralNIHDoDMRCEuropean CommissionVANIHRCZIGovernment of SpainVersus Arthritis, UKGatesNHMRCInnovation Fund DenmarkNSFNSERCSFIWellcomeNMRCGBMFARCNSFCKWFAIRC Foundation for Cancer Research in ItalyHHMIFNRSCCSCIHRDFFAcademy of FinlandINSERMHEABBSRCMSFHRUK Research & InnovationDamon Runyon Cancer Research FoundationHFSPOICRSusan G. Komen
2 artigos não disponíveis publicamente
Identification of transcription factors associated with castration‐resistance: Is the serum responsive factor a potential therapeutic target?
M Prencipe, SF Madden, A O'Neill, G O'Hurley, A Culhane, D O'Connor, ...
The Prostate 73 (7), 743-753, 2013
Autorizações: Science Foundation Ireland
The 1+ Million Genomes Minimal Dataset for Cancer
M Riba, C Sala, AC Culhane, Å Flobak, A Patocs, K Boye, K Plevova, ...
Nature Genetics, 1-4, 2024
Autorizações: European Commission
65 artigos disponíveis publicamente
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Autorizações: US Department of Defense, US National Institutes of Health
Repeatability of published microarray gene expression analyses
JPA Ioannidis, DB Allison, CA Ball, I Coulibaly, X Cui, AC Culhane, ...
Nature genetics 41 (2), 149-155, 2009
Autorizações: US National Institutes of Health
survcomp: an R/Bioconductor package for performance assessment and comparison of survival models
MS Schröder, AC Culhane, J Quackenbush, B Haibe-Kains
Bioinformatics 27 (22), 3206-3208, 2011
Autorizações: US National Institutes of Health
Dimension reduction techniques for the integrative analysis of multi-omics data
C Meng, OA Zeleznik, GG Thallinger, B Kuster, AM Gholami, AC Culhane
Briefings in bioinformatics 17 (4), 628-641, 2016
Autorizações: US National Institutes of Health
A three-gene model to robustly identify breast cancer molecular subtypes
B Haibe-Kains, C Desmedt, S Loi, AC Culhane, G Bontempi, ...
Journal of the National Cancer Institute 104 (4), 311-325, 2012
Autorizações: US National Institutes of Health
A multivariate approach to the integration of multi-omics datasets
C Meng, B Kuster, AC Culhane, AM Gholami
BMC bioinformatics 15, 1-13, 2014
Autorizações: US National Institutes of Health
Reporting guidelines for human microbiome research: the STORMS checklist
C Mirzayi, A Renson, Genomic Standards Consortium, ...
Nature medicine 27 (11), 1885-1892, 2021
Autorizações: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Enter the matrix: factorization uncovers knowledge from omics
GL Stein-O’Brien, R Arora, AC Culhane, AV Favorov, LX Garmire, ...
Trends in Genetics 34 (10), 790-805, 2018
Autorizações: US Department of Defense, US National Institutes of Health, Gordon and Betty …
Taxonomy of breast cancer based on normal cell phenotype predicts outcome
S Santagata, A Thakkar, A Ergonul, B Wang, T Woo, R Hu, JC Harrell, ...
The Journal of clinical investigation 124 (2), 859-870, 2014
Autorizações: US National Institutes of Health
Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples
M Riester, W Wei, L Waldron, AC Culhane, L Trippa, E Oliva, S Kim, ...
Journal of the National Cancer Institute 106 (5), dju048, 2014
Autorizações: US National Institutes of Health
An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence
E Dhimolea, R de Matos Simoes, D Kansara, A Al’Khafaji, J Bouyssou, ...
Cancer cell 39 (2), 240-256. e11, 2021
Autorizações: US Department of Defense, US National Institutes of Health
Gene Expression Atlas update—a value-added database of microarray and sequencing-based functional genomics experiments
M Kapushesky, T Adamusiak, T Burdett, A Culhane, A Farne, A Filippov, ...
Nucleic acids research 40 (D1), D1077-D1081, 2012
Autorizações: US National Institutes of Health
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
DT Chen, A Nasir, A Culhane, C Venkataramu, W Fulp, R Rubio, T Wang, ...
Breast cancer research and treatment 119, 335-346, 2010
Autorizações: US National Institutes of Health
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled …
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
MedRxiv, 2020
Autorizações: US National Institutes of Health, Versus Arthritis, UK, National Institute …
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome
ZC Wang, NJ Birkbak, AC Culhane, R Drapkin, A Fatima, R Tian, ...
Clinical cancer research 18 (20), 5806-5815, 2012
Autorizações: US National Institutes of Health, National Health and Medical Research …
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
Autorizações: US Department of Defense, US National Institutes of Health, US Department of …
GeneSigDB: a manually curated database and resource for analysis of gene expression signatures
AC Culhane, MS Schröder, R Sultana, SC Picard, EN Martinelli, C Kelly, ...
Nucleic acids research 40 (D1), D1060-D1066, 2012
Autorizações: US National Institutes of Health
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ...
The Lancet Rheumatology 2 (11), e698-e711, 2020
Autorizações: US National Institutes of Health, US Department of Veterans Affairs, Versus …
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador